Bay Street News, December 17th, 2018

 Intended for U.S. Audience FDA approves Shire’s Motegrity™ (prucalopride), the only serotonin-4 receptor agonist for adults with Chronic Idiopathic Constipation […]

BOULDER, Colo., Dec. 17, 2018 (GLOBE NEWSWIRE) — DMC Global Inc. (Nasdaq: BOOM) today announced its board of directors has […]

TAMPA, Fla., Dec. 17, 2018 (GLOBE NEWSWIRE) — LGI Homes, Inc. (Nasdaq:LGIH) is now selling new homes near Tampa in […]

CALGARY, Alberta, Dec. 17, 2018 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE) (NYSE […]

TORONTO, Dec. 17, 2018 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G) is pleased […]

TORONTO, Dec. 17, 2018 (GLOBE NEWSWIRE) — Snipp Interactive Inc. (“Snipp” or the “Company”) (OTCQB: SNIPF; TSX-V: SPN), a global […]

SAINT-MICHEL-DES-SAINTS, Quebec, Dec. 17, 2018 (GLOBE NEWSWIRE) — Nouveau Monde Graphite Inc. (“NMG”) (TSX-V : NOU) is proud to present […]

– Company Will Focus on Four Childhood Neuropsychiatric Disorders: FXS, DEE, Autism Spectrum Disorder and 22q11.2 Deletion Syndrome – – […]

BarreGEN® is Interpace’s Lead Molecular Diagnostic Pipeline Product for Barrett’s Esophagus Parsippany, NJ, Dec. 17, 2018 (GLOBE NEWSWIRE) — Interpace Diagnostics […]

GONZALES, La., Dec. 17, 2018 (GLOBE NEWSWIRE) — Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) today announced the launch of […]